Medical School · Year 2 · Pathology · includes a quiz and discussion video

Lecture 05: Genetic Disorders

Unit 2.11: Pathology

Learning Objectives

By the end of this lecture, students will be able to:

1. Describe the types of genetic disorders and patterns of inheritance
2. Explain common Mendelian disorders
3. Describe chromosomal abnormalities and their consequences
4. Explain trinucleotide repeat disorders
5. Describe mitochondrial inheritance
6. Explain multifactorial inheritance and genetic testing

Lecture Outline

I. Overview of Genetic Disorders

Genetic disorders encompass a broad spectrum of diseases caused by abnormalities in the genome, ranging from single nucleotide changes to entire chromosome aberrations. The classification of genetic disorders includes single gene (Mendelian) disorders caused by mutations in individual genes, chromosomal disorders involving abnormalities in chromosome number or structure, and multifactorial disorders resulting from the combined effects of multiple genes and environmental factors. Mitochondrial disorders represent a distinct category with their unique maternal inheritance pattern. Understanding the genetic basis of disease has become increasingly important as advances in molecular diagnostics and targeted therapies transform clinical practice.

The patterns of inheritance for Mendelian disorders follow predictable rules that allow risk calculation and genetic counseling. Autosomal dominant disorders require only one mutant allele to produce the phenotype, with affected individuals typically having one affected parent and a 50% chance of transmitting the condition to offspring. Autosomal recessive disorders require two mutant alleles, with carrier parents each having a 25% chance of having an affected child with each pregnancy. X-linked recessive disorders predominantly affect males who carry the single mutant allele on their X chromosome, while females are typically carriers with varying degrees of expression. Mitochondrial inheritance is exclusively maternal, as mitochondria are transmitted through the egg cytoplasm.

The concepts of penetrance and expressivity are essential for understanding the clinical manifestations of genetic disorders. Penetrance refers to the proportion of individuals with a particular genotype who express the associated phenotype, with complete penetrance meaning all carriers are affected and reduced penetrance meaning some carriers escape clinical manifestations. Expressivity describes the range of phenotypic severity among individuals with the same genotype, explaining why family members with identical mutations may have vastly different disease manifestations. Variable expressivity is common in autosomal dominant conditions such as neurofibromatosis type 1, where affected family members may range from mildly to severely affected.

Mutations can be classified by their effect on the encoded protein and their clinical consequences. Missense mutations substitute one amino acid for another, with functional consequences depending on the biochemical properties of the substituted amino acid and its position in the protein. Nonsense mutations create premature stop codons, typically resulting in truncated, nonfunctional proteins. Frameshift mutations, caused by insertions or deletions not divisible by three, alter the reading frame and usually produce nonfunctional proteins. Splice site mutations disrupt normal RNA processing, while trinucleotide repeat expansions represent a unique class of mutations with distinctive clinical features including anticipation.

<image>Panel A: Diagram showing the four major types of genetic disorders - single gene (Mendelian), chromosomal, multifactorial, and mitochondrial - with examples and relative frequencies. Panel B: Pedigree patterns illustrating autosomal dominant (vertical transmission), autosomal recessive (horizontal, consanguinity), and X-linked recessive (affected males, carrier females) inheritance. Panel C: Illustration of penetrance and expressivity concepts showing individuals with same genotype but different phenotypic expression. Panel D: Types of mutations including missense, nonsense, frameshift, and splice site with their effects on protein structure and function.</image>

II. Autosomal Dominant Disorders

Autosomal dominant disorders are characterized by vertical transmission through generations, with affected individuals typically having one affected parent and passing the condition to approximately half of their offspring regardless of sex. These disorders often involve structural proteins, receptors, or regulatory molecules where reduction to 50% normal protein function (haploinsufficiency) or production of abnormal protein with dominant-negative effects causes disease. New mutations account for a significant proportion of cases, particularly for conditions that reduce reproductive fitness. The clinical expression of autosomal dominant disorders frequently shows age-dependent penetrance, with manifestations developing over time rather than being present at birth.

Marfan syndrome exemplifies an autosomal dominant connective tissue disorder caused by mutations in the FBN1 gene encoding fibrillin-1, a glycoprotein component of extracellular matrix microfibrils. The incidence is approximately 1 in 5000, with one-quarter of cases representing new mutations. Skeletal manifestations include tall stature, arachnodactyly (long, spider-like fingers), pectus deformities, scoliosis, and joint hypermobility. The ocular hallmark is ectopia lentis, typically with upward lens dislocation, occurring in 50-80% of patients. The most serious manifestations are cardiovascular, including aortic root dilation leading to aortic dissection, aortic regurgitation, and mitral valve prolapse, which are the major determinants of morbidity and mortality.

Familial hypercholesterolemia results from mutations affecting the LDL receptor pathway, most commonly loss-of-function mutations in the LDLR gene encoding the LDL receptor itself. Heterozygotes, with a frequency of approximately 1 in 500, have plasma cholesterol levels 2-3 times normal and develop premature atherosclerotic cardiovascular disease, typically in the fourth or fifth decade. Homozygotes are rare (approximately 1 in 1 million) but devastating, with cholesterol levels 5-6 times normal and cardiovascular events in childhood or adolescence if untreated. Clinical features include tendon xanthomas (cholesterol deposits in tendons, especially the Achilles tendon), xanthelasma (cholesterol deposits in eyelid skin), and corneal arcus (cholesterol deposits in the peripheral cornea).

Additional important autosomal dominant disorders include neurofibromatosis type 1 (NF1), caused by mutations in the NF1 tumor suppressor gene, characterized by cafe-au-lait macules, neurofibromas, Lisch nodules, and increased tumor susceptibility. Huntington disease involves CAG trinucleotide repeat expansion in the HTT gene with progressive neurodegeneration. Autosomal dominant polycystic kidney disease (ADPKD) affects approximately 1 in 1000 individuals and is caused by mutations in PKD1 or PKD2, with progressive cyst formation leading to renal failure. Von Willebrand disease, affecting approximately 1% of the population, involves deficiency or dysfunction of von Willebrand factor causing mucocutaneous bleeding.

<image>Panel A: Clinical features of Marfan syndrome showing tall stature with arm span exceeding height, arachnodactyly, pectus excavatum, and lens dislocation, alongside diagram of aortic root dilation. Panel B: LDL receptor pathway diagram showing normal function versus defective receptor in familial hypercholesterolemia, with resulting cholesterol accumulation and clinical features including tendon xanthomas. Panel C: Neurofibromatosis type 1 features including multiple cafe-au-lait macules, cutaneous neurofibromas, and Lisch nodules on iris examination. Panel D: Comparison of clinical features and genetics of major autosomal dominant disorders including Marfan, FH, NF1, and Huntington disease.</image>

III. Autosomal Recessive Disorders

Autosomal recessive disorders manifest when both alleles of a gene are mutated, typically requiring inheritance of one mutant allele from each carrier parent. The characteristic pedigree pattern is horizontal, with affected individuals in a single generation and unaffected parents who are carriers. Consanguinity increases the risk of autosomal recessive conditions by increasing the probability that both parents carry the same rare mutation inherited from a common ancestor. Unlike autosomal dominant disorders, which often involve structural proteins, autosomal recessive disorders frequently involve enzymes, where residual function from a single normal allele is sufficient for normal phenotype (carriers are unaffected).

Cystic fibrosis is the most common lethal autosomal recessive disorder in Caucasian populations, with an incidence of approximately 1 in 2500 and a carrier frequency of approximately 1 in 25. The disease results from mutations in the CFTR gene encoding a chloride channel, with the deltaF508 deletion accounting for approximately 70% of mutant alleles. Defective chloride transport leads to abnormally thick, viscous secretions in multiple organs. Pulmonary manifestations include chronic airway infection, particularly with Pseudomonas aeruginosa, bronchiectasis, and progressive respiratory failure, which is the primary cause of death. Pancreatic exocrine insufficiency causes malabsorption and steatorrhea, while meconium ileus may present in newborns.

Phenylketonuria (PKU) results from deficiency of phenylalanine hydroxylase (PAH), the enzyme that converts phenylalanine to tyrosine. Affected individuals cannot metabolize dietary phenylalanine, which accumulates and is converted to neurotoxic metabolites. Without treatment, severe intellectual disability, seizures, and behavioral problems develop. A musty or mousy body odor results from phenylacetic acid excretion, and affected individuals often have fair skin and hair due to reduced melanin synthesis. Newborn screening programs detect elevated phenylalanine levels, enabling early dietary restriction of phenylalanine that prevents neurologic damage when initiated in the first weeks of life.

Additional important autosomal recessive disorders include sickle cell disease, caused by a point mutation in the beta-globin gene creating hemoglobin S that polymerizes when deoxygenated, causing red cell sickling and vaso-occlusive crises. Tay-Sachs disease results from hexosaminidase A deficiency causing GM2 ganglioside accumulation in neurons, with infantile onset and rapid neurologic deterioration. Gaucher disease, the most common lysosomal storage disorder, involves glucocerebrosidase deficiency causing glucocerebroside accumulation in macrophages (Gaucher cells) with hepatosplenomegaly and bone disease. Wilson disease results from defective copper transport, causing copper accumulation in liver and brain with hepatic and neuropsychiatric manifestations.

<image>Panel A: Cystic fibrosis pathophysiology showing defective CFTR chloride channel, thick mucus production in airways, chronic infection cycle, and pancreatic duct obstruction with consequences. Panel B: Phenylketonuria metabolic pathway showing blocked conversion of phenylalanine to tyrosine, accumulation of phenylalanine and neurotoxic metabolites, with newborn screening by heel prick test. Panel C: Sickle cell disease showing hemoglobin S polymerization, red cell sickling, and vaso-occlusion with clinical manifestations. Panel D: Comparison of major lysosomal storage diseases including Tay-Sachs, Gaucher, and others showing enzyme deficiency, accumulated substrate, and clinical features.</image>

IV. X-Linked Disorders

X-linked recessive disorders predominantly affect males because they possess only one X chromosome and therefore express any mutant allele they carry (hemizygous). Female carriers typically have mild or no manifestations due to the presence of a normal allele on the other X chromosome, though random X-inactivation (lyonization) can occasionally produce symptomatic carriers when the normal X is preferentially inactivated. The characteristic pedigree pattern shows no male-to-male transmission (fathers transmit their Y chromosome to sons), affected males in multiple generations connected through carrier females, and carrier mothers transmitting the condition to 50% of their sons.

Duchenne muscular dystrophy (DMD) is the most common and severe form of muscular dystrophy, affecting approximately 1 in 3500 male births. The disease results from mutations in the DMD gene, which is the largest known human gene, encoding the protein dystrophin. Most mutations are frameshift deletions that ablate dystrophin expression entirely. The clinical course is characterized by progressive muscle weakness beginning at ages 2-5 years, with difficulty climbing stairs and the characteristic Gower sign in which children use their hands to "walk up" their legs when rising from the floor. Pseudohypertrophy of the calves results from replacement of muscle with fat and connective tissue, and serum creatine kinase is markedly elevated. Wheelchair dependence typically develops by age 12, and death from respiratory or cardiac complications occurs in the third decade.

Hemophilia A and B are bleeding disorders caused by deficiency of coagulation factors VIII and IX respectively, with hemophilia A being 5-6 times more common. Both are X-linked recessive, causing bleeding diathesis primarily in males. Severity correlates with factor levels, with severe disease (less than 1% factor activity) causing spontaneous bleeding, moderate disease (1-5%) causing bleeding with minor trauma, and mild disease (5-25%) causing excessive bleeding primarily with surgery or major trauma. Hemarthrosis (bleeding into joints) is the hallmark manifestation, causing painful acute episodes and progressive joint destruction if recurrent.

Glucose-6-phosphate dehydrogenase (G6PD) deficiency affects over 400 million people worldwide, with highest prevalence in populations from malaria-endemic regions where heterozygosity confers protection against malaria. G6PD is essential for generating NADPH, which protects red blood cells from oxidative damage. Affected individuals are usually asymptomatic until exposed to oxidant stresses including certain drugs (primaquine, sulfonamides, nitrofurantoin), fava beans, or infections, which trigger acute hemolytic episodes. Fragile X syndrome, caused by CGG repeat expansion in the FMR1 gene, is the most common inherited cause of intellectual disability and the second most common genetic cause after Down syndrome, with characteristic features including macroorchidism, large ears, and long face.

<image>Panel A: X-linked inheritance pedigree showing affected males, carrier females, and the absence of male-to-male transmission with typical family patterns. Panel B: Duchenne muscular dystrophy showing dystrophin localization in normal muscle versus absence in DMD, clinical features including Gower sign and pseudohypertrophy, and disease progression timeline. Panel C: Hemophilia showing the coagulation cascade with factor VIII and IX positions, clinical manifestations of hemarthrosis, and severity classification by factor level. Panel D: G6PD deficiency showing the role of G6PD in protecting red cells from oxidative stress, triggers of hemolysis, and peripheral blood smear during hemolytic crisis with bite cells.</image>

V. Chromosomal Disorders

Chromosomal disorders involve abnormalities in chromosome number or structure that are large enough to be visible by conventional cytogenetic analysis. Numerical abnormalities include aneuploidy, defined as a chromosome number that is not an exact multiple of the haploid number (23 in humans). Trisomy involves presence of an extra chromosome (47 total), while monosomy involves absence of a chromosome (45 total). Polyploidy refers to complete extra sets of chromosomes, which is usually lethal in humans. The most common mechanism for numerical abnormalities is nondisjunction, the failure of homologous chromosomes or sister chromatids to separate properly during meiosis.

Down syndrome (trisomy 21) is the most common chromosomal disorder compatible with survival, occurring in approximately 1 in 700 live births. The incidence increases dramatically with maternal age, from 1 in 1500 at maternal age 20 to 1 in 25 at age 45, reflecting increased meiotic nondisjunction in aging oocytes. Characteristic facial features include a flat facial profile, upslanting palpebral fissures, epicanthal folds, and a protruding tongue. Intellectual disability is universal, with IQ typically in the range of 25-50. Congenital heart defects, particularly atrioventricular canal defects, occur in approximately 40% of affected individuals. Increased risk of acute leukemia and early-onset Alzheimer disease are additional features.

Turner syndrome (45,X) is the most common sex chromosome abnormality in females, resulting from complete or partial absence of one X chromosome. Unlike most monosomies, which are lethal, Turner syndrome is compatible with survival because one X is normally inactivated in females. Clinical features include short stature, webbed neck with low posterior hairline, broad chest with widely spaced nipples, and lymphedema of hands and feet in newborns. The ovaries are streak gonads without functional follicles, causing primary amenorrhea and infertility. Cardiovascular abnormalities, particularly coarctation of the aorta and bicuspid aortic valve, occur with increased frequency. Intelligence is typically normal.

Klinefelter syndrome (47,XXY) is the most common sex chromosome abnormality in males, occurring in approximately 1 in 650 male births. Affected individuals are phenotypically male due to the presence of the Y chromosome but have features resulting from the extra X chromosome. Clinical manifestations include tall stature, gynecomastia, small firm testes, and infertility due to azoospermia from seminiferous tubule dysgenesis. Testosterone levels are reduced, contributing to reduced facial hair, female-pattern pubic hair, and reduced muscle mass. Mild cognitive impairment may be present, though intelligence is often normal. The risk of breast cancer is increased to levels approaching those of females.

<image>Panel A: Diagram of nondisjunction during meiosis I and II showing how aneuploidy arises, with normal versus abnormal chromosome segregation to gametes. Panel B: Down syndrome features including characteristic facial appearance, palmar crease, and cardiac defect diagram, with graph showing maternal age relationship. Panel C: Turner syndrome showing lymphedema in newborn, webbed neck, and streak ovaries, with karyotype demonstrating 45,X. Panel D: Klinefelter syndrome features including tall stature, gynecomastia, and testicular histology showing seminiferous tubule dysgenesis, with 47,XXY karyotype.</image>

VI. Structural Chromosomal Abnormalities

Structural chromosomal abnormalities result from breakage and abnormal rejoining of chromosome segments, producing various rearrangements visible on cytogenetic analysis. Deletions involve loss of a chromosomal segment, producing partial monosomy for the genes in the deleted region. Duplications involve presence of an extra copy of a chromosomal segment, producing partial trisomy. Inversions occur when a segment is inverted 180 degrees relative to the rest of the chromosome, which may be paracentric (not including the centromere) or pericentric (including the centromere). Translocations involve transfer of genetic material between chromosomes, classified as reciprocal (exchange between non-homologous chromosomes) or Robertsonian (fusion of acrocentric chromosomes at their centromeres).

Translocations can be balanced, with no net gain or loss of genetic material, or unbalanced, with gain or loss of chromosomal content. Balanced translocation carriers typically have normal phenotypes but are at risk of producing gametes with unbalanced chromosome complements, leading to offspring with chromosomal abnormalities or recurrent pregnancy loss. Robertsonian translocations involving chromosome 21 can produce familial Down syndrome when the carrier parent transmits both the translocated chromosome and a normal chromosome 21. Unlike trisomy 21 from nondisjunction, which is usually sporadic, translocation Down syndrome has recurrence risk determined by the carrier parent's translocation.

Microdeletion syndromes involve deletion of chromosomal segments too small to be detected by conventional karyotyping but detectable by fluorescence in situ hybridization (FISH) or chromosomal microarray. DiGeorge syndrome results from deletion of chromosome 22q11.2 and presents with the CATCH-22 mnemonic: Cardiac defects (particularly conotruncal abnormalities), Abnormal facies, Thymic hypoplasia (with T-cell immunodeficiency), Cleft palate, and Hypocalcemia (from parathyroid hypoplasia). Williams syndrome results from deletion of 7q11.23, causing distinctive elfin facies, intellectual disability with relative preservation of language skills, a characteristic friendly "cocktail party" personality, supravalvular aortic stenosis, and hypercalcemia.

Prader-Willi and Angelman syndromes illustrate the phenomenon of genomic imprinting, in which phenotype depends on whether a mutation is inherited from the mother or father. Both syndromes involve the same chromosomal region (15q11-13), but deletion of the paternal copy causes Prader-Willi syndrome while deletion of the maternal copy causes Angelman syndrome. Prader-Willi syndrome features hypotonia in infancy followed by hyperphagia and obesity, short stature, hypogonadism, mild intellectual disability, and characteristic behavioral problems. Angelman syndrome features severe intellectual disability, ataxic gait, seizures, and a characteristic happy affect with frequent laughter, leading to the historical (now outdated) term "happy puppet syndrome."

<image>Panel A: Types of structural chromosomal abnormalities illustrated with chromosome diagrams showing deletion, duplication, inversion (paracentric and pericentric), and translocation (reciprocal and Robertsonian). Panel B: Balanced versus unbalanced translocations showing normal phenotype in balanced carriers but risk of unbalanced offspring, with Robertsonian translocation Down syndrome example. Panel C: DiGeorge syndrome 22q11.2 deletion showing FISH analysis, characteristic facial features, and CATCH-22 acronym with clinical manifestations. Panel D: Genomic imprinting at 15q11-13 showing how paternal deletion causes Prader-Willi syndrome while maternal deletion causes Angelman syndrome, with contrasting clinical features.</image>

VII. Trinucleotide Repeat Disorders

Trinucleotide repeat disorders represent a unique class of genetic diseases caused by expansion of repetitive three-nucleotide sequences beyond a normal threshold, producing unstable mutations that tend to expand further during transmission to offspring. The characteristic clinical feature of these disorders is anticipation, in which successive generations experience earlier onset and/or more severe disease as the repeat expansion grows. The expanded repeats can occur in coding regions, where they produce abnormal proteins with expanded polyglutamine tracts, or in non-coding regions, where they affect gene expression or RNA function. The mechanism of repeat instability during DNA replication involves slipped-strand mispairing.

Huntington disease is the prototypical polyglutamine disease, caused by CAG repeat expansion in the HTT gene encoding huntingtin protein. Normal alleles contain 6-35 repeats, while disease-causing alleles have 36 or more repeats, with severity inversely related to repeat number. The disease typically presents in the fourth or fifth decade with a triad of movement disorder (chorea, or involuntary dance-like movements), cognitive decline progressing to dementia, and psychiatric disturbances including depression and personality changes. Neuropathologically, there is marked atrophy of the caudate nucleus and putamen. Anticipation occurs particularly with paternal transmission, with juvenile-onset cases typically inheriting expanded alleles from affected fathers.

Fragile X syndrome, the most common inherited cause of intellectual disability, results from CGG repeat expansion in the 5' untranslated region of the FMR1 gene. Normal alleles contain 5-44 repeats; premutation alleles with 55-200 repeats are unstable and prone to expansion to full mutation (more than 200 repeats) when transmitted by females. Full mutation alleles are hypermethylated and transcriptionally silenced, preventing production of FMRP protein. Affected males have moderate to severe intellectual disability, macroorchidism (large testes), long face, prominent ears, and often autism spectrum features. Fragile X tremor-ataxia syndrome (FXTAS) affects older male premutation carriers, causing progressive cerebellar ataxia and tremor.

Additional trinucleotide repeat disorders include myotonic dystrophy type 1, caused by CTG expansion in DMPK, which is the most common muscular dystrophy in adults, characterized by myotonia (delayed muscle relaxation), progressive weakness, cataracts, and cardiac conduction abnormalities. Friedreich ataxia, caused by GAA expansion in FXN, is an autosomal recessive ataxia with onset typically before age 25, progressive gait and limb ataxia, absent deep tendon reflexes, cardiomyopathy, and diabetes. The spinocerebellar ataxias (SCAs) are a heterogeneous group of dominantly inherited ataxias, many caused by CAG expansions affecting different genes.

<image>Panel A: Mechanism of trinucleotide repeat expansion showing slipped-strand mispairing during DNA replication leading to progressively larger expansions through generations, with illustration of anticipation. Panel B: Huntington disease showing CAG repeat ranges for normal, intermediate, and disease alleles, brain MRI/pathology with caudate atrophy, and clinical triad of chorea, cognitive decline, and psychiatric symptoms. Panel C: Fragile X syndrome showing CGG repeat ranges from normal through premutation to full mutation, hypermethylation mechanism, and characteristic clinical features. Panel D: Comparison of major trinucleotide repeat disorders showing repeat sequence, gene, location (coding versus non-coding), and clinical features.</image>

VIII. Mitochondrial Inheritance

Mitochondrial inheritance is characterized by exclusive maternal transmission because mitochondria are inherited from the egg cytoplasm, with sperm contributing essentially no mitochondrial DNA to the zygote. Mitochondrial DNA (mtDNA) is a circular 16.5 kilobase genome encoding 13 proteins essential for oxidative phosphorylation, as well as transfer RNAs and ribosomal RNAs required for mitochondrial protein synthesis. Unlike nuclear genes, mtDNA is present in multiple copies per cell, with thousands of mitochondria each containing multiple genome copies. This high copy number underlies the phenomenon of heteroplasmy.

Heteroplasmy refers to the coexistence of normal and mutant mitochondrial genomes within the same cell, tissue, or individual. The proportion of mutant mtDNA determines the severity of disease, with higher mutant loads generally causing more severe phenotypes. A threshold effect exists for most mitochondrial disorders, with clinical manifestations appearing only when the mutant load exceeds a critical percentage (typically 60-90% depending on the tissue and mutation). The distribution of mutant mtDNA among cells during cell division is random, leading to varying mutant loads in different tissues and explaining the often unpredictable phenotypic expression of mitochondrial disorders.

Tissues with high energy demands are most vulnerable to mitochondrial dysfunction because they depend most heavily on oxidative phosphorylation. The central nervous system, skeletal muscle, and cardiac muscle are particularly affected, explaining why mitochondrial disorders commonly present with encephalopathy, myopathy, and cardiomyopathy. The term "mitochondrial myopathy" encompasses disorders affecting muscle, characterized histologically by ragged red fibers on modified Gomori trichrome staining, which represent subsarcolemmal accumulation of abnormal mitochondria. The clinical features often include exercise intolerance, weakness, and lactic acidosis.

Specific mitochondrial disorders include MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes), characterized by recurrent stroke-like episodes often occurring before age 40, seizures, dementia, and migraine-like headaches. MERRF (Myoclonic Epilepsy with Ragged Red Fibers) features myoclonus, seizures, cerebellar ataxia, and myopathy. Leber hereditary optic neuropathy causes rapid, bilateral vision loss from optic nerve degeneration, typically affecting young adult males despite equal transmission to both sexes. Kearns-Sayre syndrome, caused by large mtDNA deletions, presents with progressive external ophthalmoplegia, pigmentary retinopathy, and cardiac conduction defects.

<image>Panel A: Diagram of maternal inheritance pattern showing mitochondria transmitted exclusively through the egg, with pedigree demonstrating affected mothers transmitting to all children while affected fathers do not transmit. Panel B: Concept of heteroplasmy illustrated with cells containing varying proportions of normal and mutant mitochondria, threshold effect for disease expression, and random segregation during cell division. Panel C: Ragged red fiber histology showing modified Gomori trichrome stain with characteristic subsarcolemmal red granular material representing abnormal mitochondrial accumulation. Panel D: Clinical features of major mitochondrial disorders including MELAS (stroke-like lesions on MRI), MERRF (myoclonus), and Leber optic neuropathy (optic disc appearance).</image>

IX. Multifactorial Inheritance

Multifactorial inheritance refers to the combined effects of multiple genes, each contributing a small amount to disease susceptibility, together with environmental factors that modify expression. Unlike Mendelian disorders caused by highly penetrant mutations in single genes, multifactorial diseases represent the cumulative effect of many common genetic variants, each with modest effect sizes. This genetic architecture, sometimes called complex inheritance, underlies the majority of common diseases including diabetes mellitus, hypertension, coronary artery disease, and most cancers, as well as common congenital malformations.

The threshold model provides a conceptual framework for understanding multifactorial inheritance. According to this model, liability to disease is continuously distributed in the population, with disease occurring when liability exceeds a threshold. Genetic and environmental factors both contribute to liability. Relatives of affected individuals have increased liability due to shared genetic variants, producing recurrence risks that are lower than Mendelian ratios but higher than population prevalence. Recurrence risk increases with the number of affected family members, severity of disease in the proband, and closeness of relationship to the affected individual.

Examples of multifactorial conditions include neural tube defects such as spina bifida and anencephaly, which result from failure of neural tube closure during embryonic development. Both genetic susceptibility (including variants affecting folate metabolism) and environmental factors (particularly folate deficiency) contribute. Periconceptional folic acid supplementation dramatically reduces recurrence risk. Cleft lip with or without cleft palate demonstrates multifactorial inheritance with recurrence risk of approximately 4% for first-degree relatives of an affected individual, compared to population prevalence of approximately 1 in 1000.

Common adult diseases with multifactorial inheritance include type 2 diabetes mellitus, with heritability of approximately 50% and identified susceptibility genes including TCF7L2, hypertension with significant genetic contribution modified by sodium intake, obesity, and stress, and coronary artery disease with genetic susceptibility compounded by modifiable risk factors. Psychiatric disorders including schizophrenia, bipolar disorder, and autism spectrum disorders show high heritability but complex genetic architecture with many contributing variants. Genome-wide association studies (GWAS) have identified numerous susceptibility variants for these conditions, though individually each variant confers only modest risk.

<image>Panel A: Comparison of single-gene (Mendelian) versus multifactorial inheritance showing large effect of single mutation versus cumulative small effects of many genes plus environment. Panel B: Threshold model for multifactorial inheritance showing continuous distribution of liability in population, threshold for disease expression, and shift in liability distribution for relatives of affected individuals. Panel C: Neural tube defects as multifactorial condition showing interaction between genetic variants (folate metabolism genes) and environmental factors (folate intake), with effect of supplementation on recurrence. Panel D: GWAS approach for identifying susceptibility variants showing Manhattan plot of genome-wide significance and the polygenic nature of complex disease risk.</image>

X. Genetic Testing and Diagnosis

Cytogenetic analysis forms the foundation of genetic diagnosis for chromosomal disorders, with the G-banded karyotype remaining the standard method for detecting aneuploidies and large structural abnormalities. Karyotyping requires dividing cells and therefore takes several days for results. The resolution of conventional karyotyping is approximately 5-10 megabases, limiting detection of smaller abnormalities. Fluorescence in situ hybridization (FISH) uses fluorescently labeled DNA probes to detect specific chromosomal sequences, enabling rapid detection of common aneuploidies and targeted detection of microdeletions and specific translocations such as BCR-ABL in chronic myeloid leukemia.

Chromosomal microarray analysis (CMA) has largely replaced karyotyping as the first-tier test for developmental delay, intellectual disability, and congenital anomalies. CMA detects copy number variants (CNVs) - deletions and duplications - throughout the genome at resolution far exceeding conventional karyotyping. Array comparative genomic hybridization (array CGH) compares patient DNA to reference DNA to detect CNVs. SNP arrays additionally detect loss of heterozygosity, which may indicate uniparental disomy or consanguinity. CMA cannot detect balanced rearrangements or low-level mosaicism, situations where karyotyping remains valuable.

Molecular genetic testing at the DNA sequence level has been transformed by next-generation sequencing (NGS) technologies. Targeted gene panels sequence multiple genes associated with a specific phenotype or disease category. Whole exome sequencing (WES) sequences all coding regions (exons) of the genome, approximately 1-2% of total genomic DNA but containing approximately 85% of known disease-causing variants. Whole genome sequencing (WGS) sequences the entire genome including non-coding regions. The diagnostic yield of WES for suspected genetic disorders ranges from 25-50% depending on the indication, with ongoing improvement as knowledge of genetic variation expands.

Prenatal genetic diagnosis encompasses multiple approaches to detect genetic disorders before birth. Chorionic villus sampling (CVS) at 10-12 weeks and amniocentesis at 15-18 weeks provide fetal cells for karyotyping, microarray, or molecular testing, but carry small procedure-related miscarriage risks. Cell-free fetal DNA testing analyzes fetal DNA circulating in maternal blood, providing non-invasive prenatal screening for common aneuploidies with high sensitivity and specificity, though it remains a screening test requiring confirmation. Preimplantation genetic testing examines embryos created through in vitro fertilization before transfer, enabling selection of unaffected embryos for couples at high risk of genetic disease.

<image>Panel A: Comparison of cytogenetic techniques showing G-banded karyotype for detecting aneuploidies and large structural changes, FISH for rapid detection of specific abnormalities, and microarray for genome-wide CNV detection. Panel B: Next-generation sequencing approaches showing progression from targeted panels to exome to genome sequencing with tradeoffs between breadth and depth of coverage. Panel C: Prenatal diagnosis timeline showing options at different gestational ages including CVS, amniocentesis, cell-free fetal DNA, and their relative characteristics. Panel D: Genetic counseling process showing components including risk assessment, test selection, result interpretation, and psychosocial support.</image>

Summary

• Mendelian disorders follow single-gene inheritance patterns: autosomal dominant, autosomal recessive, or X-linked
• Autosomal dominant disorders include Marfan syndrome, familial hypercholesterolemia, and neurofibromatosis type 1 with vertical transmission
• Autosomal recessive disorders require two mutant alleles; examples include cystic fibrosis, PKU, and sickle cell disease with 25% recurrence risk to carrier parents
• X-linked recessive disorders affect males primarily; examples include Duchenne muscular dystrophy and hemophilia
• Chromosomal disorders include trisomies (Down syndrome), sex chromosome abnormalities (Turner, Klinefelter), and structural abnormalities
• Microdeletion syndromes (DiGeorge, Williams) and imprinting disorders (Prader-Willi, Angelman) require specialized detection
• Trinucleotide repeat disorders show anticipation; examples include Huntington disease and Fragile X syndrome
• Mitochondrial disorders show maternal inheritance, heteroplasmy, and tissue-specific threshold effects
• Multifactorial inheritance involves multiple genes plus environment; includes most common diseases
• Genetic testing includes karyotyping, FISH, microarray, and next-generation sequencing with prenatal options

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown